Menu
Recruiting NCT06814977

An Acupuncture Study for Cancer Survivors With Joint Pain

No phase Interventional Cancer Survivor

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Acupuncture.
Who it may be relevant to
Registry conditions: Cancer Survivor. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Researching the Implementation of Acupuncture for Chronic Musculoskeletal Pain in Diverse Underserved Cancer Survivors (ReIMAGINE)

Overview

The purpose of this study is to see whether acupuncture is a practical (feasible) treatment for cancer survivors with joint pain.

Interventions

  • Procedure Acupuncture
    Acupuncture is a non-pharmacological intervention that does not involve the use of any therapeutic agents or devices. Participants will receive 10 weekly treatments over 10 weeks.

Primary outcome measures

  • Study feasibility as measured by rates of enrollment [Time frame: 1 year]

Eligibility criteria

Inclusion criteria

  • English- or Spanish-speaking adults
  • Non white or Hispanic women with a prior cancer diagnosis
  • Stable oncological disease or no evidence oncological of disease per clinical documentation or clinician assessment
  • Worst pain rated ≥4 on a 0-10 scale in the preceding week
  • ≥15 days with pain in the past 30 days
  • Pain lasting ≥1 month
  • Willing and able to complete questionnaires and other study activities
  • Willing and able to provide informed consent for the trial

Exclusion criteria

  • Completed active treatment (chemotherapy, surgery, radiation, transplantation) <4 weeks prior to study
  • Maintenance therapies are allowed
  • Pain attributed to inflammatory arthritis (e.g., rheumatoid arthritis, gout)
  • Other non-musculoskeletal pain syndromes (eg, headache, visceral abdominal pain, neuropathic pain) can be present as comorbid conditions if the patient reports musculoskeletal pain as the primary source of pain
  • Procedures involving affected joints within the last month or planned in the next 14 weeks
  • Acupuncture use for pain in the past three months
  • Implanted electronic device (e.g., pacemaker)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Non-randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 2 centers
  • Memorial Sloan Kettering Cancer Center (All protocol activites) — New York
  • Jamaica Hospital Medical Center — Richmond Hill

Identifiers

NCT: NCT06814977 · 24-305

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗